Research output per year
Research output per year
Personal profile
Headline
ASSISTANT PROFESSOR, Medicine, Gastroenterology
Fingerprint
Dive into the research topics where Ari M. Grinspan is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Author Correction: Gut microbiota strain richness is species specific and affects engraftment (Nature, (2025), 637, 8045, (422-429), 10.1038/s41586-024-08242-x)
Chen-Liaw, A., Aggarwala, V., Mogno, I., Haifer, C., Li, Z., Eggers, J., Helmus, D., Hart, A., Wehkamp, J., Lamousé-Smith, E. S. N., Kerby, R. L., Rey, F. E., Colombel, J. F., Kamm, M. A., Olle, B., Norman, J. M., Menon, R., Watson, A. R., Crossette, E. & Terveer, E. M. & 7 others, , 13 Feb 2025, In: Nature. 638, 8050, p. E4Research output: Contribution to journal › Comment/debate
-
Gut microbiota strain richness is species specific and affects engraftment
Chen-Liaw, A., Aggarwala, V., Mogno, I., Haifer, C., Li, Z., Eggers, J., Helmus, D., Hart, A., Wehkamp, J., Lamousé-Smith, E. S. N., Kerby, R. L., Rey, F. E., Colombel, J. F., Kamm, M. A., Olle, B., Norman, J. M., Menon, R., Watson, A. R., Crossett, E. & Terveer, E. M. & 7 others, , 9 Jan 2025, In: Nature. 637, 8045, p. 422-429 8 p., 25.Research output: Contribution to journal › Article › peer-review
21 Scopus citations -
Safety and Tolerability of CP101, a Full-Spectrum, Oral Microbiome Therapeutic for the Prevention of Recurrent Clostridioides difficile Infection: A Phase 2 Randomized Controlled Trial
Allegretti, J. R., Kelly, C. R., Louie, T., Fischer, M., Hota, S., Misra, B., Van Hise, N. W., Yen, E., Bullock, J. S., Silverman, M., Davis, I., McGill, S. K., Pardi, D. S., Orenstein, R., Grinspan, A., El-Nachef, N., Feuerstadt, P., Borody, T. J., Khanna, S. & Budree, S. & 1 others, , Feb 2025, In: Gastroenterology. 168, 2, p. 357-366.e3Research output: Contribution to journal › Article › peer-review
9 Scopus citations -
Discharge: How Should You Follow and Care for Patients After Fecal Microbiota Transplantation?
Grinspan, L. T. & Grinspan, A. M., 1 Jan 2024, The 6 Ds of Fecal Microbiota Transplantation: A Primer From Decision to Discharge and Beyond. CRC Press, p. 93-102 10 p.Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review
-
Microbiota therapeutics for inflammatory bowel disease: the way forward
Bethlehem, L., Estevinho, M. M., Grinspan, A., Magro, F., Faith, J. J. & Colombel, J. F., May 2024, In: The Lancet Gastroenterology and Hepatology. 9, 5, p. 476-486 11 p.Research output: Contribution to journal › Review article › peer-review
Open Access38 Scopus citations
Press/Media
-
U.S. Clinical Trial: Icahn School of Medicine at Mount Sinai Listed a New Clinical Trial to Study MTC Versus FMT in for RCDI
22/06/23
1 item of Media coverage
Press/Media
-
Studies from Icahn School of Medicine at Mount Sinai in the Area of Medical Devices and Surgical Technology Described (Systematic Review With Meta-analysis: Fecal Microbiota Transplantation for Severe or Fulminant Clostridioides Difficile)
Grinspan, L., Ungaro, R., Luo, Y. & Grinspan, A. M.
14/11/22
1 item of Media coverage
Press/Media
-
Microbes Behind Successful Fecal Microbiota Transplantations May Become Basis for New Treatments
28/09/21
1 item of Media coverage
Press/Media
-
Potential alterative to FMT in bacteria may restore gut microbiome
27/09/21
1 item of Media coverage
Press/Media